RTN4R and malignant pleural mesothelioma: Human NGR-TNF (NGR-hTNF) has been evaluated alone or in combination with chemotherapy in several phase-I and -II studies enrolling patients with various types of solid tumors, and in also in a phase-III study in patients with malignant pleural mesothelioma.